Logo image of COO.CA

OSTROM CLIMATE SOLUTIONS INC (COO.CA) Stock Fundamental Analysis

TSX-V:COO - TSX Venture Exchange - CA6886041079 - Common Stock - Currency: CAD

0.035  -0.01 (-22.22%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to COO. COO was compared to 14 industry peers in the Health Care Equipment & Supplies industry. COO may be in some trouble as it scores bad on both profitability and health. COO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year COO has reported negative net income.
COO had a negative operating cash flow in the past year.
COO had negative earnings in 4 of the past 5 years.
In multiple years COO reported negative operating cash flow during the last 5 years.
COO.CA Yearly Net Income VS EBIT VS OCF VS FCFCOO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -333.85%, COO is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -333.85%
ROE N/A
ROIC N/A
ROA(3y)-123.79%
ROA(5y)-79.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COO.CA Yearly ROA, ROE, ROICCOO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

With a Gross Margin value of 29.41%, COO is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of COO has declined.
COO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.53%
GM growth 5Y-16.78%
COO.CA Yearly Profit, Operating, Gross MarginsCOO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

COO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COO has been increased compared to 1 year ago.
The number of shares outstanding for COO has been increased compared to 5 years ago.
COO has a worse debt/assets ratio than last year.
COO.CA Yearly Shares OutstandingCOO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COO.CA Yearly Total Debt VS Total AssetsCOO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

COO has an Altman-Z score of -37.43. This is a bad value and indicates that COO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -37.43, COO is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -37.43
ROIC/WACCN/A
WACC7.07%
COO.CA Yearly LT Debt VS Equity VS FCFCOO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M -3M -4M

2.3 Liquidity

A Current Ratio of 0.19 indicates that COO may have some problems paying its short term obligations.
COO has a worse Current ratio (0.19) than 66.67% of its industry peers.
A Quick Ratio of 0.16 indicates that COO may have some problems paying its short term obligations.
COO's Quick ratio of 0.16 is on the low side compared to the rest of the industry. COO is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.16
COO.CA Yearly Current Assets VS Current LiabilitesCOO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for COO have decreased strongly by -46.27% in the last year.
Looking at the last year, COO shows a very negative growth in Revenue. The Revenue has decreased by -36.66% in the last year.
Measured over the past years, COO shows a small growth in Revenue. The Revenue has been growing by 3.97% on average per year.
EPS 1Y (TTM)-46.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.24%
Revenue 1Y (TTM)-36.66%
Revenue growth 3Y-1.46%
Revenue growth 5Y3.97%
Sales Q2Q%-31.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COO.CA Yearly Revenue VS EstimatesCOO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COO.CA Price Earnings VS Forward Price EarningsCOO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COO.CA Per share dataCOO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OSTROM CLIMATE SOLUTIONS INC

TSX-V:COO (8/14/2025, 7:00:00 PM)

0.035

-0.01 (-22.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-28 2025-05-28
Earnings (Next)08-27 2025-08-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.74%
Ins Owner ChangeN/A
Market Cap3.99M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.03
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -333.85%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.41%
FCFM N/A
ROA(3y)-123.79%
ROA(5y)-79.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.53%
GM growth 5Y-16.78%
F-Score2
Asset Turnover2.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.16
Altman-Z -37.43
F-Score2
WACC7.07%
ROIC/WACCN/A
Cap/Depr(3y)55.27%
Cap/Depr(5y)49.25%
Cap/Sales(3y)0.23%
Cap/Sales(5y)0.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-36.66%
Revenue growth 3Y-1.46%
Revenue growth 5Y3.97%
Sales Q2Q%-31.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-72.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-258.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-262.97%
OCF growth 3YN/A
OCF growth 5YN/A